The Journal of Neuropsychiatry and Clinical Neurosciences
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by Gonzalez-Pinto, A.
* Articles by Mico, J. A.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Gonzalez-Pinto, A.
* Articles by Mico, J. A.
Related Collections
* Depression
J Neuropsychiatry Clin Neurosci 14:206-209, May 2002
© 2002 American Psychiatric Press, Inc.


Clinical and Research Reports

Efficacy and Safety of Venlafaxine-ECT Combination in Treatment-Resistant Depression

Ana Gonzalez-Pinto, M.D., Miguel Gutierrez, M.D., Nekane Gonzalez, M.D., Edorta Elizagarate, M.D., Jose L. Perez de Heredia, M.D. and Juan A. Mico, M.D.

Received November 20, 2000; revised February 10, 2001; accepted February 22, 2001. From Hospital Santiago Apostol, Department of Psychiatry, Vitoria, Spain (A.G.-P., M.G., N.G., E.E., J.L.P.H.), and the Department of Neuroscience, Neuropsychopharmacology Unit, Faculty of Medicine, University of Cádiz, Spain (J.A.M.). Address correspondence to Dr. Gonzalez-Pinto, Hospital Santiago Apostol, Department of Psychiatry, Olaguibel 29, Vitoria, Basque Country, Spain. E-mail: agonzalez{at}sscc.osakidetza.net

ABSTRACT

Thirteen patients with treatment-resistant major depression were given venlafaxine, at doses ranging from 150 mg to 375 mg, combined with ECT. Propofol was used as an anesthetic. Ten of 13 (76.9%) were considered responsive to combined ECT-venlafaxine treatment, and positive responses were not associated with venlafaxine doses. An asystole episode was observed in 4 patients; these patients had received significantly higher doses of venlafaxine (P<0.01). Treatment seems to be safe at venlafaxine doses <300 mg/day. At higher doses, with propofol used as anesthetic, the possibility of asystole cannot be ruled out. A possible additive effect of high-dose venlafaxine and propofol-blocking sodium channels are discussed.

Key Words: Venlafaxine • ECT • Depression







Get information about faster international access.

Privacy Policy

Copyright © 2002 American Neuropsychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Neuropsychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org